ARTICLE | Distillery Therapeutics
Toxin-derived YBX1 inhibitor for ovarian cancer
April 7, 2021 5:05 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Ovarian cancer...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Cancer
INDICATION: Ovarian cancer...
BCIQ Company Profiles
BCIQ Target Profiles